Researchers develop a new blood test for pancreatic cancer that accurately detects 71% of cases.

Scientists from the Van Andel Institute and the University of Pittsburgh have developed a new blood test for pancreatic cancer that correctly identified 71% of cancer samples, compared to 44% by the current method. The test, which is being evaluated by a commercial lab, could potentially detect pancreatic cancer earlier in high-risk individuals and monitor treatment progress. If successful, it could be a significant improvement in diagnosing and managing the disease.

2 months ago
3 Articles